PMID- 20003377 OWN - NLM STAT- MEDLINE DCOM- 20100218 LR - 20240317 IS - 1471-2334 (Electronic) IS - 1471-2334 (Linking) VI - 9 DP - 2009 Dec 12 TI - Association of HLA-A, B, DRB1 alleles and haplotypes with HIV-1 infection in Chongqing, China. PG - 201 LID - 10.1186/1471-2334-9-201 [doi] AB - BACKGROUND: The human immunodeficiency virus type 1(HIV-1) epidemic in Chongqing, China, is increasing rapidly with the dominant subtype of CRF07_BC over the past 3 years. Since human leukocyte antigen (HLA) polymorphisms have shown strong association with susceptibility/resistance to HIV-1 infection from individuals with different ethnic backgrounds, a recent investigation on frequencies of HLA class I and class II alleles in a Chinese cohort also indicated that similar correlation existed in HIV infected individuals from several provinces in China, however, such information is unavailable in Chongqing, southwest China. METHODS: In this population-based study, we performed polymerase chain reaction analysis with sequence-specific oligonucleotide probes (PCR-SSOP) for intermediate-low-resolution HLA typing in a cohort of 549 HIV-1 infected individuals, another 2475 healthy subjects from the Han nationality in Chongqing, China, were selected as population control. We compared frequencies of HLA-A, B, DRB1 alleles, haplotypes and genotypes between the two groups, and analyzed their association with HIV-1 susceptibility or resistance. RESULTS: The genetic profile of HLA (A, B, DRB1) alleles of HIV-1 infected individuals from Chongqing Han of China was obtained. Several alleles of HLA-B such as B*46 (P = 0.001, OR = 1.38, 95%CI = 1.13-1.68), B*1501G(B62) (P = 0.013, OR = 1.42, 95%CI = 1.08-1.88), B*67 (P = 0.022, OR = 2.76, 95%CI = 1.16-6.57), B*37 (P = 0.014, OR = 1.93, 95%CI = 1.14-3.28) and B*52 (P = 0.038, OR = 1.64, 95%CI = 1.03-2.61) were observed to have association with susceptibility to HIV-1 infection in this population. In addition, the haplotype analysis revealed that A*11-B*46, A*24-B*54 and A*01-B*37 for 2-locus, and A*11-B*46-DRB1*09, A*02-B*46-DRB1*08, A*11-B*4001G-DRB1*15, A*02-B*4001G-DRB1*04, A*11-B*46-DRB1*08 and A*02-B*4001G-DRB1*12 for 3-locus had significantly overrepresented in HIV-1 infected individuals, whereas A*11-B*1502G, A*11-B*1502G-DRB1*12 and A*33-B*58-DRB1*13 were underrepresented. However, the low-resolution homozygosity of HLA-A, B, DRB1 loci and HLA-Bw4/Bw6 genotypes did not differ significantly between the two groups. CONCLUSION: These results may contribute to the database of HLA profiles in HIV-1 infected Chinese population, consequently, the association of certain HLA alleles with susceptibility or resistance to HIV-1 infection would provide with clues in choosing proper preventive strategies against HIV-1 infection and developing effective HIV-1 vaccines in Chinese population, especially for those in southwest China. FAU - Huang, Xia AU - Huang X AD - Department of Epidemiology, Third Military Medical University, Chongqing, PR China. FAU - Ling, Hua AU - Ling H FAU - Mao, Wei AU - Mao W FAU - Ding, Xianbin AU - Ding X FAU - Zhou, Quanhua AU - Zhou Q FAU - Han, Mei AU - Han M FAU - Wang, Fang AU - Wang F FAU - Cheng, Lei AU - Cheng L FAU - Xiong, Hongyan AU - Xiong H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091212 PL - England TA - BMC Infect Dis JT - BMC infectious diseases JID - 100968551 RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Adolescent MH - Adult MH - Alleles MH - Case-Control Studies MH - China/epidemiology MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - Genetics, Population MH - HIV Infections/*genetics/immunology MH - HLA-A Antigens/*genetics MH - HLA-B Antigens/*genetics MH - HLA-DR Antigens/*genetics MH - HLA-DRB1 Chains MH - Haplotypes MH - Humans MH - Logistic Models MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Young Adult PMC - PMC2797796 EDAT- 2009/12/17 06:00 MHDA- 2010/02/19 06:00 PMCR- 2009/12/12 CRDT- 2009/12/17 06:00 PHST- 2008/12/29 00:00 [received] PHST- 2009/12/12 00:00 [accepted] PHST- 2009/12/17 06:00 [entrez] PHST- 2009/12/17 06:00 [pubmed] PHST- 2010/02/19 06:00 [medline] PHST- 2009/12/12 00:00 [pmc-release] AID - 1471-2334-9-201 [pii] AID - 10.1186/1471-2334-9-201 [doi] PST - epublish SO - BMC Infect Dis. 2009 Dec 12;9:201. doi: 10.1186/1471-2334-9-201.